ࡱ> EGD bjbjWW :55T T $P",N&jv&x&x&x&x&x&x&$(I+h&^&&PPPFv&Pv&PPr"%T"&&MD@v%b&&0&%+j+"&+"&@P&&P&+T t: Permission to Gather Personal Health Information (PHI) There are two common approaches to gathering Personal Health Information (PHI): 1) directly from an individual or, if a minor, an individuals parent/guardian; and 2) requesting information from an entity such the individuals health provider, hospital, clinic, or health plan. I. Directly from an individual. Principal Investigators asking research subjects to personally provide Personal Health Information (e.g., current health problems, current medications, past serious illness/injuries/surgeries, etc.), should include the following on the Informed Consent Form (or Parental Permission form), in addition to the standard ICF language. Insert the following after the Statement of Your Consent but above the signature line: Disclosure of Personal Health Information: I authorize[INSERT name of PI] and the researchers staff [OPTIONAL: and any collaborators, other clinical sites involved in this research, sponsors if applicable, outside laboratories] to use my [my childs] individual health information for the purpose of conducting this research project. My [My childs] individual health information that may be used to conduct this research includes: [INSERT list of all individual health information to be collected for this protocol/study, such as demographic information, results of physical exams, blood tests, x-rays, and other diagnostic and medical procedures, as well as medical history]. If I receive [my child receives] compensation for participating in this study, identifying information about me [my child] may be used as necessary to provide compensation. __________________________________________________________________________________________ II. Requesting information from an entity. If asking permission to access research subjects Personal Health Information (e.g., current health problems, current medications, past serious illness/injuries/surgeries, etc.) from an entity such the individuals health provider, hospital, clinic, or health plan, the Principal Investigator must include the form Authorization to Disclose Protected Health Information for Research Purposes (see next page) in addition to the Informed Consent Form or, in the case of a minor, the Parental Permission form. Note: As always, the IRB approval stamp must appear on the informed consent form (ICF) or Parental Permission form, if appropriate, whether or not the ICF includes permission to gather personal health information. If requesting subjects personal health information from an entity, the IRB approval stamp must appear on both the ICF (or Parental Permission form, if appropriate) and HIPAA Authorization Form (below). If you have any questions, please contact Paula Baker, IRB Chair, at 243-6672 or email  HYPERLINK "mailto:paula.baker@umontana.edu" paula.baker@umontana.edu.  Authorization to Use and Disclose Protected Health Information for Research Purposes  Purpose. I authorize [INSERT name of entity with protected health information, e.g., health provider, hospital, clinic, health plan] to disclose to [INSERT name of PI] the following protected health information: [INSERT list of all individual health information to be collected for this protocol/study, such as demographic information, results of physical exams, blood tests, x-rays, and other diagnostic and medical procedures, as well as medical history]. This protected health information is to be used/disclosed by [INSERT name of PI] and the researchers staff [OPTIONAL: and any collaborators, other clinical sites involved in this research, sponsors if applicable, outside laboratories] only for the purpose of conducting the research project entitled [INSERT title of study]. Right to Refuse. I may refuse to sign this authorization if I so choose. If I decide not to sign the Authorization, I will not be allowed to participate in this study or receive any research related treatment that is provided through the study. However, my decision not to sign this authorization will not affect my current or future other treatment, current or future payment, enrollment in health plans, or eligibility for benefits at The ؿ (if applicable). Right to Revoke. At all times, I retain the right to revoke this Authorization. Such revocation must be submitted in writing to [INSERT name of entity with protected health information, e.g., hospital, clinic, health provider, health plan]. Withdrawal of this Authorization shall be effective except to the extent that [INSERT name of PI] has already used or disclosed information released prior to receiving notice of the revocation. Potential for Re-disclosure. I understand that once my health information is disclosed under this Authorization, there is a potential that it could be re-disclosed outside this study and no longer covered by this Authorization. I also understand that there are laws that may require my individual health information to be disclosed for public purposes, such as if required for mandated reporting of abuse or neglect, judicial proceedings, health oversight activities and public health measures.  This Authorization does not have an expiration date. I am the research participant or personal representative authorized to act on behalf of the participant. I have read this information, and I will receive a copy of this authorization form after it is signed. ___________________________________ _________________________________ Signature of research participant Date or research participants personal representative ___________________________________ _________________________________ Printed name of research participant Description of personal representatives authority or research participants personal representative to act on behalf of research participant      PAGE 3 7:DgR T U q ; A B t   B C D P Q W c   5 V g h j m z ĸٰᢗrjjj__hQh$CJaJhsg"CJaJhQhsg"56CJaJhQhsg"6CJaJhQhsg"CJaJhsg"5CJ\aJhQh$5CJ\aJh$CJaJhth*5CJaJh$5CJaJh$h$5CJaJh*CJaJhth*CJaJ hUh*hsg"h*5CJaJ$78:Q R   D j rsAB Hgd*^gdsg"^gd$^gdsg"gd$gd*$a$gd* 4?rs!%&.1fCy%ƽƱxxmxxaxjhFOPCJUaJhthFOPCJaJhFOPCJaJh*CJaJhth*CJaJhth*5CJaJh$5CJaJh*5CJaJhth*CJ\aJhsg"CJ\aJhQh$CJ\aJh$CJaJhQh$CJaJhQh$56CJaJhQh$6CJaJ&%&>?ABCD#239Etu{h}X.3ĸ{oo{oo{og{ooo{oggh*CJaJhth*6CJaJhth*56CJaJhth*CJaJhth*5CJaJ jhth*UmHnHu hth*hsg"h*5CJaJhsg"h*CJaJh*hthFOPCJaJhFOPCJaJhhnhFOP0JCJaJjhFOPCJUaJ(stlmTUVGIJQRS^gd*gd*$a$gd* $ Ha$gd**MNj$Vt,-GHOPQSBxmh"hsg"CJaJjhsg"UmHnHuhsg"CJaJh*OJQJ^Jh*CJaJh*(jhth*CJUaJmHnHuhth*6CJ]aJhth*6CJaJhth*56CJaJhth*5CJaJh*CJaJhth*CJaJ(B     $$& #$a$dgd*  !gd*   h"hsg"CJaJhsg"mHnHujh*Uh*h|jh|UB 00P1F:p*/ =!8"8#8$8% DpB 00P1F:psg"/ =!8"8#8$%  Dpn ʻ0/Pk0PNG  IHDR>Ax pHYs  iCCPPhotoshop ICC profilexc``$PPTR~!11 !/?/020|pYɕ4\PTp(%8 CzyIA c HRvA cHvH3c OIjE s~AeQfzFcJ~RBpeqIjng^r~QA~QbIj ^<#U*( >1H.-*%CC"C= o]KW0cc btY9y!K[z,٦}cg͡3#nM4}2?~ 4] cHRMz%u0`:o_FIDATx1rF?Ȳb{r# 2gyJ <Q' Hh8A LƱ86iʒb  v߯z'!&3@åFrќ8nGwd_Ptg++M ;d0Dz?nZވD#=ʌ~w9`zkk{$@8ڐ_ ?u1q$` Ixf$bpb4ȔMHFSDHR2Ko-ݵmA]h`BAY6#qΪ LEOs{vC;F{ ]pd[h)  F1tQh4&C lopĝ5ۡB&U548؜@Im˩Xh&H$jWHV_"^! 4V#ܤ 667}R*x@og+m=~.T eIHKk 'x<^-x 'p~$  G6) T`I2A#f{t faMb;'X@@X(dGgek;Bs?hd(*''bB.i_TĆ?T4a,cáHáٓMF&F5ERi|*$1 * )>H i|p$)lrR9!. sIkP")) і}DI`yBI4 r<$ߨPT}(~(5ȑݑ!U$Bx8o<Z m'q҉pm"fwO<5YmgU)Qh"* Ef@o P @H?K<Α$,@bg$D1|<@ fH˫;ll'"|Z$iv0C%9>Br|rF3.'{|Li1C0@-! i l #,byD#ŐgR(pug>a9fѠ᳾'DZJ2gr9yS8x_-o;=Wӻ/@no^+w"3zKnG/9IENDB`^ 666666666vvvvvvvvv66666>6666666666666666666666666666666666666666666666666hH6666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~_HmH nH sH tH L`L Normal1$7$8$H$CJ_HaJmH sH tH DA`D Default Paragraph FontRiR  Table Normal4 l4a (k (No List <& < Footnote ReferenceL @L NFooter !1$7$8$H$ OJQJ^JBoB N Footer CharCJOJQJ^JaJj#j z Table Grid7:V0424 t0Header  H$6oA6 t0 Header CharCJaJB'`QB !r0Comment ReferenceCJaJ4@b4 !r0 Comment TextBoqB !r0Comment Text CharCJaJHj@abH !r0Comment Subject5CJ\aJNoN !r0Comment Subject Char5CJ\aJD@D !r0 Balloon TextCJOJQJaJJoJ !r0Balloon Text CharCJOJQJaJ6U@6 FOP0 Hyperlink >*B*phPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭V$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3N)cbJ uV4(Tn 7_?m-ٛ{UBwznʜ"Z xJZp; {/<P;,)''KQk5qpN8KGbe Sd̛\17 pa>SR! 3K4'+rzQ TTIIvt]Kc⫲K#v5+|D~O@%\w_nN[L9KqgVhn R!y+Un;*&/HrT >>\ t=.Tġ S; Z~!P9giCڧ!# B,;X=ۻ,I2UWV9$lk=Aj;{AP79|s*Y;̠[MCۿhf]o{oY=1kyVV5E8Vk+֜\80X4D)!!?*|fv u"xA@T_q64)kڬuV7 t '%;i9s9x,ڎ-45xd8?ǘd/Y|t &LILJ`& -Gt/PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!0C)theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] V 0 D0  % % > X!t ,b$ʻ0/Pk0 0@H 0(  0(  D   "?D   "?  c xA&. IRB Date Stamp_pngXRSXRS"`B S  ?/@ G_&tI$(t'@     > N Vr     333333331177 A   r+#ԁ/S>|^%*?X.80^8`05o(. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.h^h`5o() 8^8`hH. L^`LhH.  ^ `hH.  ^ `hH. xL^x`LhH. H^H`hH. ^`hH. L^`LhH.^`5o() ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH.h^h`5o() 8^8`hH. L^`LhH.  ^ `hH.  ^ `hH. xL^x`LhH. H^H`hH. ^`hH. L^`LhH.%*?X/S>+#        G        P/d        q          .sg"*8KFOP|$VxJ@@UnknownG*Ax Times New Roman5Symbol3. *Cx ArialK,Bookman Old Style[Lucida GrandeCourier NewA$BCambria Math" hh'l!'l!'dn )n )! 88xx2l 3Q X?+2!xx 2/03Sheila.Hoffland Baker, Paula    Oh+'0|   , 8 D P\dlt2/03Sheila.HofflandNormalBaker, Paula7Microsoft Office Word@XG @@PP)@<n՜.+,D՜.+,H hp  The ؿ)  2/03 Title 8@ _PID_HLINKSAxK7 mailto:paula.baker@umontana.edu  !"#$%&'()*+,-./012356789:;=>?@ABCFRoot Entry FVDH1Table+WordDocument:SummaryInformation(4DocumentSummaryInformation8<CompObjr  F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q